United States Polio (Poliomyelitis) Vaccines Market Report 2018

March 2018 | 97 pages | ID: U24265F4A9BQEN
QYResearch

Abstracts

In this report, the United States Polio (Poliomyelitis) Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Polio (Poliomyelitis) Vaccines in these regions, from 2013 to 2025 (forecast).

United States Polio (Poliomyelitis) Vaccines market competition by top manufacturers/players, with Polio (Poliomyelitis) Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Sanofi
• GSK
• Bibcol
• Serum Institute
• Tiantan Biological
• IMBCA
• Panacea Biotec Ltd
• Bio-Med
• Halfkin Bio-Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Inactivated Polio Vaccine (IPV)
• Oral Polio Vaccine (OPV)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Polio (Poliomyelitis) Vaccines Market Report 2018

1 POLIO (POLIOMYELITIS) VACCINES OVERVIEW

1.1 Product Overview and Scope of Polio (Poliomyelitis) Vaccines
1.2 Classification of Polio (Poliomyelitis) Vaccines by Product Category
  1.2.1 United States Polio (Poliomyelitis) Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Polio (Poliomyelitis) Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Inactivated Polio Vaccine (IPV)
  1.2.4 Oral Polio Vaccine (OPV)
1.3 United States Polio (Poliomyelitis) Vaccines Market by Application/End Users
  1.3.1 United States Polio (Poliomyelitis) Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Research & Academic Laboratories
  1.3.3 Pharmaceutical & Biotechnology Companies
  1.3.4 Others
1.4 United States Polio (Poliomyelitis) Vaccines Market by Region
  1.4.1 United States Polio (Poliomyelitis) Vaccines Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
  1.4.3 Southwest Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
  1.4.5 New England Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
  1.4.6 The South Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
  1.4.7 The Midwest Polio (Poliomyelitis) Vaccines Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Polio (Poliomyelitis) Vaccines (2013-2025)
  1.5.1 United States Polio (Poliomyelitis) Vaccines Sales and Growth Rate (2013-2025)
  1.5.2 United States Polio (Poliomyelitis) Vaccines Revenue and Growth Rate (2013-2025)

2 UNITED STATES POLIO (POLIOMYELITIS) VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Polio (Poliomyelitis) Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Polio (Poliomyelitis) Vaccines Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Polio (Poliomyelitis) Vaccines Average Price by Players/Suppliers (2013-2018)
2.4 United States Polio (Poliomyelitis) Vaccines Market Competitive Situation and Trends
  2.4.1 United States Polio (Poliomyelitis) Vaccines Market Concentration Rate
  2.4.2 United States Polio (Poliomyelitis) Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Polio (Poliomyelitis) Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES POLIO (POLIOMYELITIS) VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Polio (Poliomyelitis) Vaccines Sales and Market Share by Region (2013-2018)
3.2 United States Polio (Poliomyelitis) Vaccines Revenue and Market Share by Region (2013-2018)
3.3 United States Polio (Poliomyelitis) Vaccines Price by Region (2013-2018)

4 UNITED STATES POLIO (POLIOMYELITIS) VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Polio (Poliomyelitis) Vaccines Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Polio (Poliomyelitis) Vaccines Revenue and Market Share by Type (2013-2018)
4.3 United States Polio (Poliomyelitis) Vaccines Price by Type (2013-2018)
4.4 United States Polio (Poliomyelitis) Vaccines Sales Growth Rate by Type (2013-2018)

5 UNITED STATES POLIO (POLIOMYELITIS) VACCINES SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Polio (Poliomyelitis) Vaccines Sales and Market Share by Application (2013-2018)
5.2 United States Polio (Poliomyelitis) Vaccines Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES POLIO (POLIOMYELITIS) VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Sanofi
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Sanofi Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bibcol
  6.3.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bibcol Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Serum Institute
  6.4.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Serum Institute Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Tiantan Biological
  6.5.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tiantan Biological Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 IMBCA
  6.6.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 IMBCA Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Panacea Biotec Ltd
  6.7.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Bio-Med
  6.8.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bio-Med Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Halfkin Bio-Pharmaceuticals
  6.9.2 Polio (Poliomyelitis) Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview

7 POLIO (POLIOMYELITIS) VACCINES MANUFACTURING COST ANALYSIS

7.1 Polio (Poliomyelitis) Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Polio (Poliomyelitis) Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Polio (Poliomyelitis) Vaccines Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES POLIO (POLIOMYELITIS) VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Polio (Poliomyelitis) Vaccines Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Polio (Poliomyelitis) Vaccines Sales Volume Forecast by Type (2018-2025)
11.3 United States Polio (Poliomyelitis) Vaccines Sales Volume Forecast by Application (2018-2025)
11.4 United States Polio (Poliomyelitis) Vaccines Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Polio (Poliomyelitis) Vaccines
Figure United States Polio (Poliomyelitis) Vaccines Market Size (K Units) by Type (2013-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume Market Share by Type (Product Category) in 2017
Figure Inactivated Polio Vaccine (IPV) Product Picture
Figure Oral Polio Vaccine (OPV) Product Picture
Figure United States Polio (Poliomyelitis) Vaccines Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Polio (Poliomyelitis) Vaccines by Application in 2017
Figure Research & Academic Laboratories Examples
Table Key Downstream Customer in Research & Academic Laboratories
Figure Pharmaceutical & Biotechnology Companies Examples
Table Key Downstream Customer in Pharmaceutical & Biotechnology Companies
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Polio (Poliomyelitis) Vaccines Market Size (Million USD) by Region (2013-2025)
Figure The West Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales (K Units) and Growth Rate (2013-2025)
Figure United States Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Polio (Poliomyelitis) Vaccines Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Polio (Poliomyelitis) Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Polio (Poliomyelitis) Vaccines Sales Share by Players/Suppliers
Figure United States Polio (Poliomyelitis) Vaccines Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Polio (Poliomyelitis) Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Polio (Poliomyelitis) Vaccines Revenue Share by Players/Suppliers
Table United States Market Polio (Poliomyelitis) Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Polio (Poliomyelitis) Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Polio (Poliomyelitis) Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Polio (Poliomyelitis) Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Polio (Poliomyelitis) Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Polio (Poliomyelitis) Vaccines Product Category
Table United States Polio (Poliomyelitis) Vaccines Sales (K Units) by Region (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales Share by Region (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Share by Region (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Market Share by Region in 2017
Table United States Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Revenue Share by Region (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Revenue Market Share by Region (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Revenue Market Share by Region in 2017
Table United States Polio (Poliomyelitis) Vaccines Price (USD/Unit) by Region (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales (K Units) by Type (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales Share by Type (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Share by Type (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Market Share by Type in 2017
Table United States Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Polio (Poliomyelitis) Vaccines by Type (2013-2018)
Figure Revenue Market Share of Polio (Poliomyelitis) Vaccines by Type in 2017
Table United States Polio (Poliomyelitis) Vaccines Price (USD/Unit) by Types (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Growth Rate by Type (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales (K Units) by Application (2013-2018)
Table United States Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Market Share by Application (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Market Share by Application in 2017
Table United States Polio (Poliomyelitis) Vaccines Sales Growth Rate by Application (2013-2018)
Figure United States Polio (Poliomyelitis) Vaccines Sales Growth Rate by Application (2013-2018)
Table Sanofi Basic Information List
Table Sanofi Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Sanofi Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Sanofi Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table GSK Basic Information List
Table GSK Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GSK Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure GSK Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure GSK Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Bibcol Basic Information List
Table Bibcol Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bibcol Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Bibcol Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Bibcol Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Serum Institute Basic Information List
Table Serum Institute Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Serum Institute Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Serum Institute Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Serum Institute Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Tiantan Biological Basic Information List
Table Tiantan Biological Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Tiantan Biological Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Tiantan Biological Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Tiantan Biological Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table IMBCA Basic Information List
Table IMBCA Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure IMBCA Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure IMBCA Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure IMBCA Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Panacea Biotec Ltd Basic Information List
Table Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Panacea Biotec Ltd Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Bio-Med Basic Information List
Table Bio-Med Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bio-Med Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Bio-Med Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Bio-Med Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Halfkin Bio-Pharmaceuticals Basic Information List
Table Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales Growth Rate (2013-2018)
Figure Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Sales Market Share in United States (2013-2018)
Figure Halfkin Bio-Pharmaceuticals Polio (Poliomyelitis) Vaccines Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Polio (Poliomyelitis) Vaccines
Figure Manufacturing Process Analysis of Polio (Poliomyelitis) Vaccines
Figure Polio (Poliomyelitis) Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Polio (Poliomyelitis) Vaccines Major Players/Suppliers in 2017
Table Major Buyers of Polio (Poliomyelitis) Vaccines
Table Distributors/Traders List
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Type in 2025
Table United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Application in 2025
Table United States Polio (Poliomyelitis) Vaccines Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Polio (Poliomyelitis) Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume Share Forecast by Region (2018-2025)
Figure United States Polio (Poliomyelitis) Vaccines Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources